Fetal Hydrothorax Treated with Pleuro-Amniotic Shunting: Fetal and Maternal Complications and Long-Term Outcomes
Fetal Diagnosis and Therapy · 2023 · 50 (2) · 115-120
DOI: 10.1159/000529334 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fetal Diagnosis and Therapy, online erschienen am 27.01.2023. Verfasst von Mariano Lanna und 10 weiteren Autor:innen. Beteiligte Einrichtung: Fetal Therapy Unit "U. Nicolini," Buzzi Children's Hospital, University of Milan, Milan, Italy. Hauptthemen laut MEDLINE: Hydrothorax. Die Arbeit wurde bisher 8-mal zitiert (Crossref).
Abstract (Originalsprache)
Introduction
We aimed to identify maternal and fetal complications and investigate postnatal and long-term outcomes of fetal hydrothorax (FHT) treated with pleuro-amniotic shunting (shunt).
Methods
Single-center retrospective observational cohort of shunt cases performed from 2000 to 2021. Risk factors for maternal complications, fetal demise, neonatal death (NND), and postnatal outcomes were identified.
Results
Out of 88 cases, 70 (79.5%) were complicated by hydrops, with an average gestational age (GA) at diagnosis of 27 weeks (range 16–34). In 16 cases, definitive etiology of FHT was identified; five cases of Noonan syndrome and three cases of monogenic disorders diagnosed by whole-exome sequencing (EPHB4, VEGFR3, RASA1). Shunt was performed at an average GA of 28 weeks (20–34), with a dislodgement in 10 cases (11.4%). Maternal: Complications occurred in three cases; survival rate was 76.1% (67/88). Follow-up data were available for 57/67 (85.1%) children. Incidence of severe neurodevelopmental impairment and pneumopathy (broncho dysplasia, persistent pulmonary hypertension of newborn, and asthma) was 5.3% and 8.8%, respectively. Post-treatment persistence of hydrops, FHT associated with genetic syndromes, and GA at birth were risk factors for fetal demise, NND, and postnatal complications.
Conclusion
In truly isolated FHT, whenever indicated, pleuro-amniotic shunting is a safe procedure associated with good survival rate and long-term outcome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fetal Therapy Unit "U. Nicolini," Buzzi Children's Hospital, University of Milan, Milan, Italy.
- Department of Women, Mother and Neonate, Buzzi Children's Hospital, University of Milan, Milan, Italy.
- Department of Preventive Medicine, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
- Department of Pediatric Pneumology, Buzzi Children's Hospital, University of Milan, Milan, Italy.
- Department of Pneumology Follow-up in Neonatology, Neonatal Intensive Care and Pediatric Surgery, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
- Clinical Genetic Service, Buzzi Children's Hospital, University of Milan, Milan, Italy.
Zitieren
APA
Lanna, M., Consonni, D., Faiola, S., Casati, D., Laoreti, A., Zavatta, A., Farolfi, A., Spaccini, L., Scelsa, B., Lista, G., & Cetin, I. (2023). Fetal Hydrothorax Treated with Pleuro-Amniotic Shunting: Fetal and Maternal Complications and Long-Term Outcomes. Fetal Diagnosis and Therapy, 50(2), 115-120. https://doi.org/10.1159/000529334
Vancouver
Lanna M, Consonni D, Faiola S, Casati D, Laoreti A, Zavatta A, et al. Fetal Hydrothorax Treated with Pleuro-Amniotic Shunting: Fetal and Maternal Complications and Long-Term Outcomes. Fetal Diagnosis and Therapy. 2023;50(2):115-120. doi:10.1159/000529334
BibTeX
@article{Lanna2023,
author = {Lanna, Mariano and Consonni, Dario and Faiola, Stefano and Casati, Daniela and Laoreti, Arianna and Zavatta, Alice and Farolfi, Andrea and Spaccini, Luigina and Scelsa, Barbara and Lista, Gianluca and Cetin, Irene},
title = {Fetal Hydrothorax Treated with Pleuro-Amniotic Shunting: Fetal and Maternal Complications and Long-Term Outcomes},
journal = {Fetal Diagnosis and Therapy},
year = {2023},
volume = {50},
number = {2},
pages = {115--120},
doi = {10.1159/000529334}
}
EUVIMED